(Q36297774)

13 August 2017

Implementation of proteomic biomarkers: making it work (English)

1 reference

13 August 2017

0 references

10

1 reference

13 August 2017

2

John P A Ioannidis

0 references

Erik Bongcam-Rudloff

5

Erik Bongcam-Rudloff

0 references

Visith Thongboonkerd

34

Visith Thongboonkerd

0 references

Christian Delles

9

Christian Delles

1 reference

13 August 2017

31

Peter Rossing

0 references

Frederik Persson

Frederik Persson

28

0 references

Aristidis S. Charonis

Aristidis Charonis

7

0 references

Mark Brönstrup

Mark Broenstrup

6

0 references

Joost P Schanstra

Joost P Schanstra

36

0 references

Antonia Vlahou

Antonia Vlahou

37

0 references

Hing Y Leung

Hing Y Leung

19

0 references

Terri Attwood

Teresa K Attwood

4

0 references

Fulvio Magni

Fulvio Magni

21

0 references

Gert Mayer

Gert Mayer

24

0 references

Harald Mischak

Harald Mischak

1

0 references

Alberto Ortiz

Alberto Ortiz

27

0 references

Goce Spasovski

33

Goce Spasovski

1 reference

13 August 2017

Karlheinz Peter

0 references

Raymond Vanholder

35

Raymond Vanholder

1 reference

13 August 2017

32

Naveed Sattar

1 reference

13 August 2017

22

Michael P Manns

1 reference

13 August 2017

15

Joachim Jankowski

1 reference

13 August 2017

20

David Maahs

1 reference

13 August 2017

12

Jochen Ehrich

1 reference

13 August 2017

3

Angel Argiles

1 reference

13 August 2017

25

Gerjan Navis

1 reference

13 August 2017

18

Tim Lankisch

1 reference

13 August 2017

8

George P Chrousos

1 reference

13 August 2017

Tomasz Dylag

11

1 reference

13 August 2017

Jesus Egido

13

1 reference

13 August 2017

Peter Findeisen

14

1 reference

13 August 2017

Robert W Johnson

16

1 reference

13 August 2017

Bruce A Julien

17

1 reference

13 August 2017

Efthymios Manolis

23

1 reference

13 August 2017

Jan Novak

26

1 reference

13 August 2017

Hans H Riese

30

1 reference

13 August 2017

21 April 2012

1 reference

European Journal of Clinical Investigation

13 August 2017

1 reference

13 August 2017

42

1 reference

13 August 2017

9

1 reference

13 August 2017

1027-1036

1 reference

Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

From single biobanks to international networks: developing e-governance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Realizing the promise of population biobanks: a new model for translation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Ethical aspects of human biobanks: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

New pathway for qualification of novel methodologies in the European Medicines Agency

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

A roadmap for successful applications of clinical proteomics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

The journey to regulation of protein-based multiplex quantitative assays

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

30 September 2017

Bring on the biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Clinical proteomics: A need to define the field and to begin to set adequate standards

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Cancer biomarkers: can we turn recent failures into success?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Proteomic biomarkers in diabetic nephropathy--reality or future promise?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Development of high-throughput mass spectrometry-based approaches for cancer biomarker discovery and implementation.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Validation of analytic methods for biomarkers used in drug development

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Preventing microalbuminuria in type 2 diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

30 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

30 September 2017

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02674.X

Surrogate end points in clinical trials: are we being misled?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Improving validation practices in "omics" research

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Basic and clinical proteomics from the EU Health Research perspective

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

European biobanks forge cross-border ties

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Comprehensive catalog of European biobanks

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Recommendations for biomarker identification and qualification in clinical proteomics

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

What makes a good predictor?: the evidence applied to coronary artery calcium score.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Common sense approaches to urinary biomarker study design

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02674.X

Genomics. Genomics, biobanks, and the trade-secret model

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464367

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

21 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02674.X

Personal genomics: information can be harmful

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22519700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2362.2012.02674.X

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

22519700

1 reference